drugset / Trial / NCT06374758

Accelerated ART Initiation for PWHIV Who Are Out of Care

NCT06374758

NaSingle-groupOpen-labelHealth-services research

Summary

The main purpose of the study is to evaluate the effectiveness, of the ACCELERATE model of care to achieve HIV viral suppression at Week 24. The study will also assess the acceptability, appropriateness, feasibility, and sustainability of the ACCELERATE model of care. The ACCELERATE model combines a standardized method for outreach, the use of telehealth for rapid access to an HIV care provider, a simplified pre-approved HIV regimen, a free 30-day medication starter supply, and re-linkage to medical care.

Timeline

Start
2024-04-29
Primary completion
2026-05-01
Completion
2026-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject bictegravir Small molecule 50 mg
Subject emtricitabine Other / unclassified 200 mg
Subject tenofovir alafenamide Small molecule 25 mg